Relationship between the prefrontal function during a cognitive task and the severity of the symptoms in patients with panic disorder: A multi-channel NIRS study

Psychiatry Research - Neuroimaging

Volumn 172, Issue 2, 2009, Pages 168-172

  Nishimura, Yukika ^a   Tanii, Hisashi ^a   Hara, Naomi ^a   Inoue, Ken ^b   Kaiya, Hisanobu ^c   Nishida, Atsushi ^d   Okada, Motohiro ^a   Okazaki, Yuji ^e  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Research Center for Panic Disorder   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^e TOKYO METROPOLITAN MATSUZAWA HOSPITAL   (Japan)

Author keywords

Agoraphobia; Anxiety disorders; Near infrared spectroscopy; Panic attack

Indexed keywords

CARBAMAZEPINE; CHLORPROMAZINE; DEOXYHEMOGLOBIN; IMIPRAMINE; LITHIUM; LOFLAZEPATE; PHENOTHIAZINE; VALPROIC ACID;

ADULT; AGORAPHOBIA; ARTICLE; BRAIN FUNCTION; COGNITION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEAR INFRARED SPECTROSCOPY; PANIC; PREFRONTAL CORTEX; PRIORITY JOURNAL; SPEECH ARTICULATION;

ADULT; AGORAPHOBIA; COGNITION; FEMALE; HEMERYTHRIN; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PANIC DISORDER; PREFRONTAL CORTEX; SEVERITY OF ILLNESS INDEX; SPECTROSCOPY, NEAR-INFRARED;

EID: 63449092250     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2009.01.001     Document Type: Article

References (29)

1. Alvarez J.A., and Emory E. Executive function and the frontal lobes: a meta-analytic review. Neuropsychology Review 16 (2006) 17-42
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed (2000), APA, Washington. DC
3. Becker E., Rinck M., and Margraf J. Memory bias in panic disorder. Journal of Abnormal Psychology 103 (1994) 396-399
4. Dantendorfer K., Prayer D., Kramer J., Amering M., Baischer W., Berger P., Schoder M., Steinberger K., Windhaber J., Imhof H., and Katschnig H. High frequency of EEG and MRI brain abnormalities in panic disorder. Psychiatry Research: Neuroimaging 68 (1996) 41-53
5. De Cristofaro M.T., Sessarego A., Pupi A., Biondi F., and Faravelli C. Brain perfusion abnormalities in drug-naive, lactate-sensitive panic patients: a SPECT study. Biological Psychiatry 33 (1993) 505-512
6. Galderisi S., Mancuso F., Mucci A., Garramone S., Zamboli R., and Maj M. Alexithymia and cognitive dysfunctions in patients with panic disorder. Psychotherapy and psychosomatics 77 (2008) 182-188
7. Gorman J.M., Kent J.M., Sullivan G.M., and Coplan J.D. Neuroanatomical hypothesis of panic disorder, revised. American Journal of Psychiatry 157 (2000) 493-505
8. Herrmann M.J., Ehlis A.C., and Fallgatter A.J. Frontal activation during a verbal-fluency task as measured by near-infrared spectroscopy. Brain Research Bulletin 61 (2003) 51-56
9. Hoshi Y. Functional near-infrared spectroscopy: potential and limitations in neuroimaging studies. International Review of Neurobiology 66 (2005) 237-266
10. Inagaki A., Inada T., Fujii Y., Yagi G., Yoshio T., and Nakamura H. Dose Equivalence of Psychotropic Drugs (1999), Seiwa Shoten Publishers, Tokyo, Japan
11. Jobsis F.F. Noninvasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters. Science 198 (1977) 1264-1267
12. Kameyama M., Fukuda M., Uehara T., and Mikuni M. Sex and age dependencies of cerebral blood volume changes during cognitive activation: a multichannel near-infrared spectroscopy study. Neuroimage 22 (2004) 1715-1721
13. Kameyama M., Fukuda M., Yamagishi Y., Sato T., Uehara T., Ito M., Suto T., and Mikuni M. Frontal lobe function in bipolar disorder: a multichannel near-infrared spectroscopy study. Neuroimage 29 (2006) 172-184
14. Kubota Y., Toichi M., Shimizu M., Mason R.A., Coconcea C.M., Findling R.L., Yamamoto K., and Calabrese J.R. Prefrontal activation during verbal fluency tests in schizophrenia-a near-infrared spectroscopy (NIRS) study. Schizophrenia Research 77 (2005) 65-73
15. Massana G., Serra-Grabulosa J.M., Salgado-Pineda P., Gasto C., Junque C., Massana J., Mercader J.M., Gomez B., Tobena A., and Salamero M. Amygdalar atrophy in panic disorder patients detected by volumetric magnetic resonance imaging. Neuroimage 19 (2003) 80-90
16. Nordahl T.E., Stein M.B., Benkelfat C., Semple W.E., Andreason P., Zametkin A., Uhde T.W., and Cohen R.M. Regional cerebral metabolic asymmetries replicated in an independent group of patients with panic disorders. Biological Psychiatry 44 (1998) 998-1006
17. Okamoto M., Dan H., Sakamoto K., Takeo K., Shimizu K., Kohno S., Oda I., Isobe S., Suzuki T., Kohyama K., and Dan I. Three-dimensional probabilistic anatomical cranio-cerebral correlation via the international 10-20 system oriented for transcranial functional brain mapping. Neuroimage 21 (2004) 99-111
18. Phillips M.L., Drevets W.C., Rauch S.L., and Lane R. Neurobiology of emotion perception I: the neural basis of normal emotion perception. Biological Psychiatry 54 (2003) 504-514
19. Prasko J., Horacek J., Zalesky R., Kopecek M., Novak T., Paskova B., Skrdlantova L., Belohlavek O., and Hoschl C. The change of regional brain metabolism (18FDG PET) in panic disorder during the treatment with cognitive behavioral therapy or antidepressants. Neuro Endocrinology Letters 25 (2004) 340-348
20. Reiman E.M., Raichle M.E., Butler F.K., Herscovitch P., and Robins E. A focal brain abnormality in panic disorder, a severe form of anxiety. Nature 310 (1984) 683-685
21. Sakai Y., Kumano H., Nishikawa M., Sakano Y., Kaiya H., Imabayashi E., Ohnishi T., Matsuda H., Yasuda A., Sato A., Diksic M., and Kuboki T. Cerebral glucose metabolism associated with a fear network in panic disorder. Neuroreport 16 (2005) 927-931
22. Sakai Y., Kumano H., Nishikawa M., Sakano Y., Kaiya H., Imabayashi E., Ohnishi T., Matsuda H., Yasuda A., Sato A., Diksic M., and Kuboki T. Changes in cerebral glucose utilization in patients with panic disorder treated with cognitive-behavioral therapy. Neuroimage 33 (2006) 218-226
23. Schlegel S., Steinert H., Bockisch A., Hahn K., Schloesser R., and Benkert O. Decreased benzodiazepine receptor binding in panic disorder measured by IOMAZENIL-SPECT. A preliminary report. European Archives of Psychiatry and Clinical Neuroscience 244 (1994) 49-51
24. Shear M.K., Brown T.A., Barlow D.H., Money R., Sholomskas D.E., Woods S.W., Gorman J.M., and Papp L.A. Multicenter collaborative panic disorder severity scale. American Journal of Psychiatry 154 (1997) 1571-1575
25. Suto T., Fukuda M., Ito M., Uehara T., and Mikuni M. Multichannel near-infrared spectroscopy in depression and schizophrenia: cognitive brain activation study. Biological Psychiatry 55 (2004) 501-511
26. Takizawa R., Kasai K., Kawakubo Y., Marumo K., Kawasaki S., Yamasue H., and Fukuda M. Reduced frontopolar activation during verbal fluency task in schizophrenia: a multi-channel near-infrared spectroscopy study. Schizophrenia Research 99 (2008) 250-262
27. van den Heuvel O.A., Veltman D.J., Groenewegen H.J., Witter M.P., Merkelbach J., Cath D.C., van Balkom A.J., van Oppen P., and van Dyck R. Disorder-specific neuroanatomical correlates of attentional bias in obsessive-compulsive disorder, panic disorder, and hypochondriasis. Archives of General Psychiatry 62 (2005) 922-933
28. Yamamoto I., Nakano Y., Watanabe N., Noda Y., Furukawa T.A., Kanai T., Takashio O., Koda R., Otsubo T., and Kamijima K. Cross-cultural evaluation of the Panic Disorder Severity Scale in Japan. Depression and Anxiety 20 (2004) 17-22
29. Zung W.W. A Self-Rating Depression Scale. Archives of General Psychiatry 12 (1965) 63-70